At the last check on Friday, UnitedHealth Group Incorporated’s (NYSE:UNH) stock was up $4.83, moving up 0.98 percent to $498.79. The average number of shares traded per day over the past five days has been 1,876,869 shares. 2 times new highs have been achieved over the past 5 days, with a -$8.40 fall in that time frame. In the last twenty days, the average volume was 2,385,447, while in the previous 50 days, it was 3,908,079.
Since last month, UNH stock retreated -1.08%. Shares of the company fell to $491.82 on 08/17/23, the lowest level in the past month. A 52-week high of $558.10 was reached on 04/13/23 after having rallying from a 52-week low of $445.68. Since the beginning of this year, UNH’s stock price has dropped by -5.92% or -$30.57, and marked a new high 3 times. However, the stock has declined by -10.63% since its 52-week high.
UNH stock investors should be aware that UnitedHealth Group Incorporated (UNH) stock had its last reported insider trading activity 30 days ago on Jul 19. WITTY ANDREW, the CEO, UHG of the company, disposed of 4,000 shares for $506.19 on Jul 19. It resulted in a $2,024,760 divestment by the insider. WITTY ANDREW sold 6,160 shares at an average price of $487.49 on Apr 27. The insider now owns 86,564 shares following the transaction. On Apr 25, EVP Chief People Officer McSweeney Erin sold 761 shares at $494.80 apiece. The transaction was valued at $376,543.
Valuation Metrics
Right now, UnitedHealth Group Incorporated (UNH) has a P/E ratio of about 22.32. The stock’s beta is 0.66. Besides these, the trailing price-to-sales (P/S) ratio of 1.31, the price-to-book (PB) ratio of 5.63, and the price-to-cash flow ratio of 11.99 may also be considered.
The latest dividend of $1.88 per share was paid out, which is 13.94% more than last year’s $1.65. On Wednesday June 7 2023, a $0.23 dividend increase was announced.
Financial Health
According to company report, the long-term debt-to-equity ratio for the quarter ending June 30 was 0.72, and the total debt-to-equity ratio was 0.80. In the year ended June 30, operating margins totaled 8.80%. Based on annual data, UNH earned $79.62 billion in gross profit and brought in $324.16 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 16.80%. Return on equity (ROE) for the past 12 months was 26.70%.
In UnitedHealth Group Incorporated’s quarter-end financial report for June 30, it reported total debt of $59.27 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. UNH’s revenue rose 13.53% to $91.93 billion during the quarter, while net income inched up to $92.9 billion. While analysts expected UnitedHealth Group Incorporated to report $5.5 quarterly earnings, the actual figure was $5.65 per share, beating the consensus estimate by 2.70%. During the quarter, the company generated $9.08 billion in EBITDA. The liabilities of UnitedHealth Group Incorporated were 192.8 billion at the end of its most recent quarter ended June 30, and its total debt was $65.59 billion. The value of shareholders’ equity is $926.3 million.
Technical Picture
This quick technical analysis looks at UnitedHealth Group Incorporated’s (UNH) price momentum. With a historical volatility rate of 15.04%, the RSI 9-day stood at 46.70% on 17 August.
With respect to its five-day moving average, the current UnitedHealth Group Incorporated price is down by -1.65% percent or -$8.40. At present, UNH shares trade -1.37% below its 20-day simple moving average and +3.67% percent above its 100-day simple moving average. However, the stock is currently trading approximately +3.63% above its SMA50 and -10.00% below its SMA200.
Stochastic coefficient K was 27.95% and Stochastic coefficient D was 39.87%, while ATR was 8.41. Given the Stochastic reading of 35.68% for the 14-day period, the RSI (14) reading has been calculated as 50.40%. As of today, the MACD Oscillator reading stands at -4.76, while the 14-day reading stands at -5.39.
Analyst Ratings
UBS reiterated its a Neutral rating on UnitedHealth Group Incorporated (NYSE: UNH) in a note to investors. The analysts firm has however raised their price target to $520, representing a possible 2.2% increase in the stock price. UnitedHealth Group Incorporated (UNH) has been rated Buy by analysts. According to 0 brokerage firms, UNH is a sell, and 4 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 3 analysts rate UnitedHealth Group Incorporated stock as buy, with 19 recommending it as overweight.
With a median target price of $567.50, the current consensus forecast for the stock is $520.00 – $650.00. Based on these forecasts, analysts predict UnitedHealth Group Incorporated (UNH) will achieve an average price target of $572.75.
